VSTM News
Verastem, Inc.
$8.65
-$0.58(-6.28%)
56
Overall
40
Value
91
Tech
39
Quality
Market Cap
$1.05B
Volume
6.09M
52W Range
$3.43 - $10.82
Target Price
$15.00
VSTM news: the latest Verastem, Inc. headlines, press releases and market updates, newest first.
Latest VSTM News
- Verastem Announces $234 Million Oncology Financing TransactionTipRanks Auto-Generated Newsdesk · Oct 14, 2026
- RBC Capital Remains a Buy on Verastem (VSTM)TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead AssetNewswire TipRanks · Sep 25, 2026
- Verastem (VSTM) Receives a Buy from H.C. WainwrightTipRanks Auto-Generated Intelligence Newsdesk · Sep 21, 2026
- RBC Capital Keeps Their Buy Rating on Verastem (VSTM)TipRanks Auto-Generated Intelligence Newsdesk · Sep 18, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VSTM | $8.65 | -6.3% | 6.09M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |